|
S&P 500 futures retreat after nearing record on Fed as Oracle disappointment drags down AI stocks: Live updates CNBCThe Fed's hawkish cut, Oracle earnings, Coca-Cola's next CEO and more in Morning Squawk CNBCWhy Oracle Is Worrying Investors About the A.I. Boom The New York TimesStock Dip-Buyers Step In After Oracle Spurs Slide: Markets Wrap Bloomberg.com
|
|
Dow jumps 600 points to record as Oracle sparks rush out of AI trade into broader market: Live updates CNBCWhy Oracle Is Worrying Investors About the A.I. Boom The New York TimesOracle Stock Is Getting Whacked. Is the AI Trade a 'Show Me Story' Now? InvestopediaOracle drags down Nvidia and other AI stocks as bubble fears intensify MarketWatch
|
|
Nasdaq slips as Oracle AI shock overshadows Fed relief ReutersOracle made a $300 billion bet on OpenAI. It's paying the price. Yahoo FinanceOracle shares tank 11%, dragging down Nvidia, CoreWeave, Micron CNBCHeard on the Street Recap: Oracle's Outlook The Wall Street Journal
|
|
Nobel Peace Prize Winner Machado Says U.S. Helped Her Leave Venezuela The New York TimesVenezuelan opposition leader says US helped her travel to Norway to accept Nobel Prize CNNInside the very tense, very wet secret mission to get María Corina Machado out of Venezuela CBS NewsVenezuelan Nobel laureate credits Trump for pressuring Maduro with ‘decisive' actions AP News
|
|
Shares in the technology company are down as investors grow anxious that its bet on artificial intelligence, and OpenAI in particular, may not pay off.
|
|
Protesters interrupt Noem hearing with Exorcist line: ‘The power of Christ compels you!' The GuardianNoem Faces Questions From House Panel Amid Immigration Crackdown The New York TimesHighlights: Kristi Noem defends Trump's immigration policies before departing early from hearing The Washington PostNoem defiant as Democrats decry Trump administration treatment of migrants PoliticoScoop: House Democrat seeks impeachment hearings into DHS Secre
|
|
A recent PitchBook report reveals a steep downward trend.
|
|
Major Weight Loss and Knee-Pain Relief Seen With New Eli Lilly Drug The New York TimesEli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial cnbc.comEli Lilly Reports Dramatic Weight Loss in Next-Gen Obesity-Drug Trial The Wall Street JournalLilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief
|
|
